We are live on ! Find out more
OPXAW

Opexa Therapeutics, Inc.
OPXAW

Delisted

OPXAW was delisted on the 20th of September, 2017.

Back to rankings

6 hedge funds and large institutions have $38K invested in Opexa Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 4 → 6 (+2)

7% less capital invested

Capital invested by funds: $41K → $38K (-$3K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.72K
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$1.9K
3
UBS Group
UBS Group
Switzerland
+$2

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$1.82K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$27K – – –
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$4K – – –
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$4K +$4.72K +256,572 New
Bank of New York Mellon
4
Bank of New York Mellon
New York
$2K +$1.9K +103,110 New
VKH
5
Virtu KCG Holdings
New York
$1K -$1.82K -98,883 -67%
UBS Group
6
UBS Group
Switzerland
– +$2 +95 New

OPXAW Hedge Fund Activity: Q1 2017 in Review

6 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Opexa Therapeutics, Inc. (OPXAW) for Q1 2017, worth a combined $38K — down 7.3% from $41K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new OPXAW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $4.72K. The largest seller was Virtu KCG Holdings, cutting an estimated $1.82K.

  • 6 institutional investors held Opexa Therapeutics, Inc. (OPXAW) as of Q1 2017, up from 4 in Q4 2016.
  • Funds reported $38K of Opexa Therapeutics, Inc. stock for Q1 2017, down 7.3% quarter-over-quarter.
  • 3 funds opened new Opexa Therapeutics, Inc. positions in Q1 2017 and 0 closed out, a net change of +3 holders.
  • The largest Opexa Therapeutics, Inc. buyer in Q1 2017 was Susquehanna International Group, an estimated $4.72K added.
  • The largest Opexa Therapeutics, Inc. seller in Q1 2017 was Virtu KCG Holdings, an estimated $1.82K sold.

Based on aggregated 13F filings for Q1 2017.